Topics

Calixar Signs Exclusive Licensing Agreement with Regeneron for Rights to its Technology for Antibody Discovery

11:21 EDT 30 Apr 2019 | Speciality Pharma Journal

Lyon, France, April 29, 2019 – Calixar SAS (Calixar), a biotechnology company specialized in native membrane protein stabilization, announces today that it has entered into an exclusive licensing agreement with Regeneron Pharmaceuticals, Inc. Under the terms of the agreement, Calixar has given Regeneron exclusive rights to its technology and expertise to conduct research and discovery …

Original Article: Calixar Signs Exclusive Licensing Agreement with Regeneron for Rights to its Technology for Antibody Discovery

NEXT ARTICLE

More From BioPortfolio on "Calixar Signs Exclusive Licensing Agreement with Regeneron for Rights to its Technology for Antibody Discovery"

Quick Search

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...